MTM Flashcards

1
Q

Choose the best answer below to describe medication therapy management (MTM):
A. MTM is a service provided exclusively by pharmacists.
B. MTM involves collaboration between healthcare professionals and patients.
C. MTM involves Communicaton exclusively between prescribers and pharmacies.
D. MTM primarily exists to help reduce drug costs for Medicare patients

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MTM services are most appropriate:
A. When a patient comes to the pharmacy to fill a prescription for a new medical conditoon
B. For long-standing patients of the pharmacy, when prescription records are complete
C. Whenever a patient asks for a help with a specific medication
D. For patients with chronic diseases and/or during care transitions

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The benefits of MTM for patients:
A. Include improved healthcare outcomes in several chronic disease states
B. Are mainly related to patient quality of life
C. Are to help patients understand their disease, but there is no impact on effectiveness of
medications
D. Are yet to be proven, but will likely be established as MTM becomes more mainstream

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The pharmacy manager in your place of employment has assigned you to support a new
MTM service. Which of the following is most suitable for the skills of a pharmacy
technician?
A. Determine which medication options would have the most side effects in a given patient
B. Gather data needed for MTM, such as medical records, prescription records from other
pharmacies, and lab results
C. Explain to prescribers why certain medications are contraindicated for the patient
D. Counsel patients in the benefits of smoking cessation

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which of the following best describes how MTM differs from other types of patient
counseling?
A. MTM is patient-centered, rather than product-centered
B. MTM is always conducted in an in-person meeting with the patient C. MTM focuses on
correcting what the patient is doing wrong D. MTM requires a physician’s order or
referral

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Key documents generated through MTM (in most settings) include:
A. Standard paper or electronic medical record
B. Templates mandated by the Centers for Medicare & Medicaid Services (CMS)
C. Personal Medication List and Action Plan
D. Drug information handouts generated by drug manufacturers

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacy technicians’ roles in generating and completing MTM documents:
A. may not involve direct patient contact
B. should not involve changing or modifying MTM templates
C. are related mainly to filing and organizing documents generated by the pharmacist
D. are critical to supporting the MTM process

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

At the start of an MTM consultation with Mr. P., you show him a template for a Personal
Medication List and say that you’ll be helping the pharmacist to fill it in. He responds, “Oh, I
already got one of those when I left the hospital.” Which of the following responses would
be most consistent with MTM principles?
A. “Okay, great! Be sure that you use that and update it regularly.”
B. “The pharmacist noticed you had other medicines that you were taking before you were
hospitalized. We’d like to create just one list and try to make it easier for you to
use.”
C. “The hospital lists are almost never right. Let’s use the one we have.”
D. “So I guess you will have two—one for the medicines you got in the hospital, and this
one for the new medicines.”

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The Personal Medication List (PML) and the Therapeutic Action Plan:
A. are not necessary unless the patient is on multiple medications
B. are key documents generated from an MTM patient encounter
C. are given to different people: the PML to the patient and the Therapeutic Action Plan to
the doctor
D. are obsolete in MTM because of new electronic medical record (EMR) systems

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

You are asked by a pharmacist to contact Dr. Wallace’s office to clarify the date when a
particular antithrombotic medication was originally prescribed. Dr. Wallace _________:
A. must comply with the request immediately
B. does not need to provide this information
C. may comply as long as the patient has a HIPAA form on file allowing for sharing of patient
information
D. will need to call the patient to ask permission in order to give you that information

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

You are able to reach Mr. Roberts by phone to remind him about his MTM appointment with
the pharmacist this Tuesday. He says he has made a written list of all the medications he
takes. You respond:
A. “Thank you, but we won’t need it. We have a list of your current medications right
here.”
B. “That’s great. A written list is the most efficient way to work.”
C. “That’s great. If you think of it, please bring in the containers as well.”
D. “Thank you. Would you also bring along the pill bottles and pill organizers, any vitamins
or supplements, OTC medications, ointments or patches, and lab reports? I can send or
email you a checklist if you like.

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When preparing records for an MTM session with Ms. L., you see that two of the
medications she was prescribed after a recent discharge from the hospital were never filled
by your pharmacy. You assume that she filled the prescription somewhere else. This would
be an example of:
A. omission error
B. commission error
C. medical records error
D. pharmacist’s error

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In the above example, what questions could the technician research to provide valuable
information for the MTM session?
A. Did the patient refill these prescriptions at a different pharmacy?
B. Was the medication intended to be taken long-term after her discharge? For how long?
C. Does the primary physician have a record of this prescription?
D. all of the above

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

A patient is asked if he has any allergies to medications. He replies “No.” He later has an
anaphylactic reaction to an antibiotic and seeks care in the emergency department. Upon review of
the chart, there was no evidence of any allergies previously noted. Is this considered a medication
error?
A. Yes, since the allergic reaction could have caused harm to the patient
B. Yes, the patient’s reporting that he had no medication allergies is considered an error
C. No, because the reaction could not have been foreseen.
D. No, because the reaction did not cause lasting harm to the patient

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For an MTM session, a patient has brought a number of oral medications that are expired and
are no longer being used. You advise this patient:
A. to leave the medications at the pharmacy for proper disposal
B. to take the medications home and dispose of them in the trash
C. to bring the medications to a local hazardous waste disposal center
D. about proper disposal based on the type of drugs and your pharmacy’s internal
policies

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MTM is an excellent way to identify and prevent medication errors because:
A. steps can be built into MTM to detect potential errors
B. the goals of MTM are directly compatible with the goals of medication error prevention
C. pharmacists are trained in patient communication and error prevention steps
D. all of the above

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Following MTM sessions with two different patients, the pharmacy technician accidentally
mixed up some of the medication history information in the MTM paperwork (Drugs for
patient A were recorded in Patient B’s paperwork). What course of action is most
conducive to an atmosphere of error prevention?
A. The technician corrects the information later, assuming that no one else has had access
to the paperwork.
B. The technician explains that he was trying to do too many things at once, and suggests
that a bigger block of time be scheduled between each MTM session.
C. The technician mentions the error to the pharmacist, who pulls the technician off MTM
duties and makes a note in the employee record.
D. The technician mentions the error to the pharmacist and pharmacy manager, who plan
a meeting to determine if system changes should be made to avoid mix-ups.

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The Medicare Advantage Plan is:
A. an “all-in-one” alternative to Medicare that combines Medicare drug coverage and a
comprehensive health plan
B. a premium program from Medicare that provides better access to physicians and services
C. a government-sponsored program providing assistance to help patients pay Part D monthly
premiums and deductibles
D. a new name for the branch of Medicare that provides drug coverage benefits

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Mr. Jones has just had an MTM meeting with the pharmacist and would like know if he qualifies
for a Medicare low-income subsidy or “Extra Help Program.” To determine eligibility for this
program, Medicare looks at:
A. annual income only
B. total assets and annual income
C. total assets and next year’s earning potential
D. how much money the person spent on medications this year

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

To help a patient determine how and when the Medicare coverage gap might affect them, the
best resource to check would be:
A. FDA Patient Network at www.FDA.gov
B. the benefits coordinator at the patient’s employer
C. Medicare PlanFinder at www.Medicare.gov
D. the patient’s MediGap provider

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Josephine D. has no health insurance, but she has recently been prescribed a high-cost
disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis. Her options are:
A. determine whether she can take a less-expensive DMARD
B. investigate whether the manufacturer’s patient assistance program (PAP) will cover the cost
of the drug for a limited time
C. determine whether she is eligible for Medicaid or another government-sponsored program
D. all of the above

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When helping patients manage drug benefits and coverage in MTM, pharmacy technicians:
A. are not allowed to ask patients specific questions about their finances
B. can only talk to patients about financial matters when the pharmacist is present
C. may discuss finances with patients
D. need to refer patients to a pharmacy benefits professional

A

C

23
Q

The proportion of all adults in the U.S. with at least one chronic health condition is:
A. 10%
B. 25%
C. 50%
D. 75%

A

C

24
Q

Modifiable risk factors for chronic disease include all of the following except:
A. unhealthy diet
B. lack of exercise
C. advanced age
D. smoking

A

C

25
Q

An example of an intermediate risk factor for congestive heart failure would be:
A. high blood pressure
B. previous surgery
C. genetic predisposition
D. use of beta blockers

A

A

26
Q

The Type 2 diabetes epidemic in the United States has been attributed mainly to:
A. the aging population
B. overweight or obesity
C. lack of health education
D. population increases in South and Southeast U.S.

A

B

27
Q

To qualify for automatic enrollment in Medicare Part D MTM, patients must meet which of
the following criteria?
A. enrollment in a supplementary insurance policy to Medicare
B. poor adherence to prescribed medications
C. use of a high-cost branded prescription
D. diagnosis of one or more chronic disease

A

D

28
Q

Jonah is a 12-year-old boy with asthma who has experienced a worsening of his condition
since joining a sports team and has had frequent visits to the emergency department. MTM
services from a pharmacist may focus on:
A. encouraging the patient to quit his sports team and focus on his illness
B. teaching the patient and family appropriate use of bronchodilators for maintenance and
rescue therapy
C. trying to get the family to reduce the number of asthma drugs this patient is taking
D. all of the above

A

B

29
Q

Polypharmacy refers to a situation in which:
A. a person uses more than one pharmacy to fill prescriptions, thus potentially duplicating
prescriptions
B. a person takes both oral and injectable medications
C. a person takes medications that were prescribed for another individual
D. a person takes multiple medication

A

D

30
Q

The “prescribing cascade” refers to:
A. the practice of using two medications to treat a particular disease when one would
work just as well
B. the practice of treating drug side effects with the use of another drug
C. when physicians are not aware of which drugs have been prescribed and add other
prescriptions that may have unsafe interactions
D. the practice of prescribing more medications based on a patient’s demand or
expectation

A

B

31
Q

Mrs. R. has been evaluated by the pharmacist during an MTM session. She has Type 2
diabetes and cardiovascular disease, and has suffered a previous heart attack. The
pharmacist notes that her case is a clear example of polypharmacy. This means:
A. the patient is taking too many medications and probably needs to discontinue some of
them
B. the patient requires all of these medications for her condition and probably can’t have
any changes
C. the patient is taking too many medications that interact or interfere with one another
D. the patient’s medications may be medically necessary, but it is worth taking a closer
look at what she is taking and how she is taking them

A

D

32
Q

The effects of a drug on the body’s cells and organs is:
A. pharmacodynamics
B. pharmacokinetics
C. pharmacogenomics

A

A

33
Q

Genetic differences in drug response is called:
A. pharmacodynamics
B. pharmacokinetics
C. pharmacogenomic

A

C

34
Q

The speed at which a drug moves through the body is:
A. pharmacodynamics
B. pharmacokinetics
C. pharmacogenomics

A

B

35
Q

At the conclusion of John R.’s first MTM session, the pharmacist is unable to develop an
accurate Personal Medication List (PML) because of many areas of discrepancy. A possible
course of action might be:
A. call the physician to verify which medications are current and should continue
B. ask the patient to keep a diary of what he is taking and when
C. follow up with other pharmacies to determine whether prescriptions are active
D. all of the above

A

D

36
Q

Which of the following statements is TRUE about the aging population in the United States?
A. People over age 65 are responsible for 50% of all hospital stays
B. People over age 65 tend to have longer hospital stays
C. The number of people between ages 65 and 75 is expected to be much greater than any
other age group by 2060
D. Men are just as likely to be age 85+ than women

A

B

37
Q

People over age 85, or the “oldest old”
A. make up a small proportion of the population who use medications
B. make up the fastest growing segment of the population
C. are a shrinking segment of the population, due to fatality from chronic conditions like
heart disease
D. are usually cared for in nursing homes where medications are closely monitored

A

B

38
Q

Which of the following is NOT considered a “geriatric syndrome?”
A. delirium (confused state)
B. urinary incontinence
C. dizziness or poor balance
D. cardiovascular disease

A

D

39
Q

Which of the following is a correct example of an age-related change that affects the
behavior or activity of drugs in the body?
A. slowed gastric motility may impair absorption of drugs
B. reduced blood flow to the liver and kidneys may affect elimination of a drug from the
body
C. fat-soluble drugs remain in the body longer
D. all of the above

A

D

40
Q

The risk for falls in an older individual is most likely to be increased by which of the
following medication categories?
A. vitamin B12
B. bisphosphonates
C. benzodiazepines
D. over the counter analgesics

A

C

41
Q

Differences between a pharmaceutical equivalent and a pharmaceutical alternative include:
A. pharmaceutical equivalents have the same active ingredients
B. pharmaceutical alternatives may contain a different salt
C. pharmaceutical alternatives may have a different dosage form (capsule/tablet)
D. all of the above

A

D

42
Q

To be considered therapeutically equivalent to a branded or reference drug, a generic must
also:
A. be a pharmaceutical equivalent
B. be biosimilar
C. be deemed by the pharmacist to be an acceptable substitution
D. have a B rating

A

A

43
Q

An AB rating means that:
A. A drug is therapeutically equivalent to the reference drug, with no known
bioequivalence problems
B. A drug is therapeutically equivalent and is given as an oral tablet or capsule
C. The drug is not therapeutically equivalent to the reference drug because of unresolved
bioequivalence issues
D. The drug is therapeutically equivalent to the reference product, but there are known or
possible bioequivalence issue

A

D

44
Q

Joanne O. is a patient receiving MTM consultation. She says she does not want to receive a
generic version of one of her drugs because she has more nausea from it than she does
with branded drug. A correct response would be:
A. The generic drug is exactly the same as the branded one: it just has a different name
B. There may be an inactive ingredient that is causing the nausea, or a difference in how
the drug is absorbed. We can ask the pharmacist to look into this.
C. If you take the drug with more food instead of on an empty stomach probably won’t
cause nausea.
D. You are probably imagining the nausea—there isn’t really any risk of that associated
with this drug.

A

B

45
Q

Among controlled substances, those with highest potential for abuse and misuse are classified
as:
a. Schedule I or II
b. Schedule III
c. Schedule IV
d. Schedule V

A

A

46
Q

While reviewing pharmacy records in preparation for an MTM session, you notice that the
patient has received prescriptions for barbiturate sleep aids, including pentobarbital, from more
than one prescriber. The patient also has multiple prescriptions for alprazolam (Xanax) and
lorazepam (Ativan). This is:
a. probably not a concern, because these are Schedule IV substances that are not highly
subject to abuse and dependence
b. a private issue between the patient and his physicians
c. a clear case of drug abuse or diversion
d. a case suggestive of possible misuse or abuse of controlled substances that should be
called to the pharmacist’s attention

A

D

47
Q

Ms. Johnson was prescribed an opioid pain reliever (hydrocodone) following a surgical
procedure. She brings it to her medication therapy management (MTM) session along with her
other medicines, but says she does not want it in the house because she’s afraid her teenage
son might find it. The best advice for her is:
a. Throw the medication in the garbage on her way out of the pharmacy
b. Leave the medication there and the pharmacy will handle disposing of it properly
c. Take the medication with her and follow procedures in the educational materials
(provide by the pharmacy) for safe disposal, which may include flushing
d. Keep the medication in case she needs it again for a future pain condition

A

C

48
Q

Electronic prescribing of controlled substances is:
a. now required by the DEA, because paper prescriptions can be forged too easily
b. permissible only in certain states
c. allowed for pharmacies that use DEA-approved software
d. prohibited due to the decreased security of electronic transmissions

A

C

49
Q

Which of the following elements is most often present in REMS?
a. Elements to Assure Safe Use (ETASU)
b. Medication Guide
c. Communication Plan
d. Implementation System

A

B

50
Q

When preparing an MTM session for John R., you notice that one of the medications he is
taking requires a REMS. Which of the following is an appropriate step?
a. Obtain the current REMS requirements from the manufacturer’s website
b. Review patient records to see if the required monitoring steps have been followed
c. Make sure that a Medication Guide is available for the pharmacist to review with the
patient during MTM
d. All of the above

A

D

51
Q

To obtain reimbursement for Medicare MTM services, the pharmacy must:
a. bill through physicians’ offices, since pharmacists cannot submit for reimbursement
b. obtain a provider number and bill directly to CMS
c. bill an insurance company or other registered Part D payer
d. become a Medicare Part D provider

A

C

52
Q

Organizations that may reimburse pharmacists for MTM services (Medicare or otherwise)
include:
a. only registered Medicare Part D sponsors
b. either Medicare or Medicaid
c. state-sponsored health plans in some states
d. any organization that wants to control healthcare costs of members

A

D

53
Q

When billing for MTM under Medicare Part D, pharmacists should bill:
a. what the pharmacist has determined to be a fair hourly rate
b. using established CPT codes for MTM
c. the estimated cost to the pharmacy based on staff time and materials
d. based on the patient’s ability to pay

A

B

54
Q

STAR ratings are:
a. a system for rating the quality of care achieved within managed care and health
insurance plans
b. a system by the Centers for Medicare & Medicaid Services for rating the quality of care
in hospitals
c. a system from the Joint Commission for rating the quality of care in hospitals
d. a system for rating quality of care in hospitals and individual physicians’ practices

A

A